Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer

Iveta Kolářová
,
Bohuslav Melichar
,
Igor Sirák
* ORCID logo ,
Jaroslav Vaňásek
,
Jiří Petera
,
Kateřina Horáčková
,
Denisa Pohanková
,
Filip Ďatelinka
,
Zuzana Šinkorová
,
Milan Vošmik
ORCID logo
Version 1 : Received: 17 January 2024 / Approved: 17 January 2024 / Online: 18 January 2024 (09:50:02 CET)

A peer-reviewed article of this Preprint also exists.

Kolářová, I.; Melichar, B.; Sirák, I.; Vaňásek, J.; Petera, J.; Horáčková, K.; Pohanková, D.; Ďatelinka, F.; Šinkorová, Z.; Vošmik, M. The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer. Curr. Oncol. 2024, 31, 1207-1220. Kolářová, I.; Melichar, B.; Sirák, I.; Vaňásek, J.; Petera, J.; Horáčková, K.; Pohanková, D.; Ďatelinka, F.; Šinkorová, Z.; Vošmik, M. The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer. Curr. Oncol. 2024, 31, 1207-1220.

Abstract

The role of postmastectomy radiotherapy and regional nodal irradiation after radical mastectomy is defined in high-risk patients with locally advanced tumors, positive margins, and unfavorable biology. The benefit of postmastectomy radiotherapy in intermediate-risk patients (T3N0 tumors) remains a matter of controversy. It has been demonstrated that radiotherapy after breast-conserving surgery lowers the locoregional recurrence rate compared with surgery alone and improves the overall survival rate. In patients with 4 or more positive lymph nodes or extracapsular extension regional lymph node irradiation is indicated regardless of the surgery type (breast-conserving surgery or mastectomy). Despite the consensus that patients with more than 3 positive lymph nodes should be treated with radiotherapy, there is a controversy regarding the recommendations for patients with one to three involved lymph nodes. In patients with N0 disease with negative findings on axillary surgery, there is a trend to administer regional lymph node irradiation in patients with a high risk of recurrence. In patients treated with neoadjuvant systemic therapy and mastectomy, adjuvant radiotherapy should be administered in case of clinical stage III and/or ≥ypN1. In patients treated with neoadjuvant systemic therapy and breast-conserving surgery, postoperative radiotherapy is indicated irrespective of pathological response.

Keywords

breast cancer; adjuvant radiotherapy; whole breast irradiation; mastectomy; breast conserving surgery; regional node irradiation; neoadjuvant chemotherapy

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.